Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
Crossref DOI link: https://doi.org/10.1186/s13045-016-0247-4
Published Online: 2016-03-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bolomsky, Arnold
Schlangen, Karin
Schreiner, Wolfgang
Zojer, Niklas
Ludwig, Heinz